Prognostic Factors of Nasopharyngeal Carcinoma Treated by Radiotherapy

Naoyuki Shigematsu, Hisao Ito, Yosuke Oki, Tetsuya Kawada, Takayuki Suzuki, Atsuya Takeda, Minoru Uematsu, Atsushi Kubo, Masato Fujii, Hitoshi Kanzaki

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

This study was a retrospective analysis of 82 patients with histologically confirmed nasopharyngeal carcinoma, who were treated at Keio University Hospital from March 1983 to March 1993. We studied all cases (62% of them were stage IV) with regard to their prognostic factors and chronic side effects induced by radiation. All patients were received extended-field radiotherapy from the base of the skull to the supraclaviclar lymph node area. The five- and ten-year overall survival rates for the entire group were 59% and 49%, respectively. Three stage I patients were alive without recurrence or métastases for more than 5 years. The ten-year survival rate stage II-III for patients (23 patients) was 78%, and for stage IV (56 patients) 37%. The five-year survival rate of patients in T2-3 group without lymph node metastasis was 88%, while it was reduced to 55% for patients with metastasis. The prognosis of T4 patients was very poor: their five-year survival rate was 37% with lymph node metastasis, and 35%, without lymph node metastasis. Patients under 46 years old showed an increased survival rate compared with patients over 46 years old. Patients who completed less than 52 days of radiation therapy found to have a better prognosis than those receiving radiation for a longer period. Our multivariate analysis indicated that age, radiation period and N-factor were statistically significant in influencing prognosis. Hearing loss occured relatively high with 2096 of cumulative incidence in our study, probably because they received radiation therapy with the extended field including bilateral midle and inner ear. Extended-field radiotherapy for patients with nasopharyngeal carcinoma might contribute to improving their cure-rate, and precise radiation planning is warranted to avoid the late complications such as hearing loss.

Original languageEnglish
Pages (from-to)1050-1055
Number of pages6
JournalNippon Acta Radiologica
Volume56
Issue number14
Publication statusPublished - 1996 Dec

Fingerprint

Radiotherapy
Survival Rate
Lymph Nodes
Neoplasm Metastasis
Radiation
Hearing Loss
Nasopharyngeal carcinoma
Radiation Effects
Skull Base
Inner Ear
Multivariate Analysis
Recurrence
Incidence

Keywords

  • Nasopharyngeal cancer
  • Prognostic factor
  • Radiotherapy

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Shigematsu, N., Ito, H., Oki, Y., Kawada, T., Suzuki, T., Takeda, A., ... Kanzaki, H. (1996). Prognostic Factors of Nasopharyngeal Carcinoma Treated by Radiotherapy. Nippon Acta Radiologica, 56(14), 1050-1055.

Prognostic Factors of Nasopharyngeal Carcinoma Treated by Radiotherapy. / Shigematsu, Naoyuki; Ito, Hisao; Oki, Yosuke; Kawada, Tetsuya; Suzuki, Takayuki; Takeda, Atsuya; Uematsu, Minoru; Kubo, Atsushi; Fujii, Masato; Kanzaki, Hitoshi.

In: Nippon Acta Radiologica, Vol. 56, No. 14, 12.1996, p. 1050-1055.

Research output: Contribution to journalArticle

Shigematsu, N, Ito, H, Oki, Y, Kawada, T, Suzuki, T, Takeda, A, Uematsu, M, Kubo, A, Fujii, M & Kanzaki, H 1996, 'Prognostic Factors of Nasopharyngeal Carcinoma Treated by Radiotherapy', Nippon Acta Radiologica, vol. 56, no. 14, pp. 1050-1055.
Shigematsu N, Ito H, Oki Y, Kawada T, Suzuki T, Takeda A et al. Prognostic Factors of Nasopharyngeal Carcinoma Treated by Radiotherapy. Nippon Acta Radiologica. 1996 Dec;56(14):1050-1055.
Shigematsu, Naoyuki ; Ito, Hisao ; Oki, Yosuke ; Kawada, Tetsuya ; Suzuki, Takayuki ; Takeda, Atsuya ; Uematsu, Minoru ; Kubo, Atsushi ; Fujii, Masato ; Kanzaki, Hitoshi. / Prognostic Factors of Nasopharyngeal Carcinoma Treated by Radiotherapy. In: Nippon Acta Radiologica. 1996 ; Vol. 56, No. 14. pp. 1050-1055.
@article{cfe19c79ad9442bdb4cce2f54cba8d5e,
title = "Prognostic Factors of Nasopharyngeal Carcinoma Treated by Radiotherapy",
abstract = "This study was a retrospective analysis of 82 patients with histologically confirmed nasopharyngeal carcinoma, who were treated at Keio University Hospital from March 1983 to March 1993. We studied all cases (62{\%} of them were stage IV) with regard to their prognostic factors and chronic side effects induced by radiation. All patients were received extended-field radiotherapy from the base of the skull to the supraclaviclar lymph node area. The five- and ten-year overall survival rates for the entire group were 59{\%} and 49{\%}, respectively. Three stage I patients were alive without recurrence or m{\'e}tastases for more than 5 years. The ten-year survival rate stage II-III for patients (23 patients) was 78{\%}, and for stage IV (56 patients) 37{\%}. The five-year survival rate of patients in T2-3 group without lymph node metastasis was 88{\%}, while it was reduced to 55{\%} for patients with metastasis. The prognosis of T4 patients was very poor: their five-year survival rate was 37{\%} with lymph node metastasis, and 35{\%}, without lymph node metastasis. Patients under 46 years old showed an increased survival rate compared with patients over 46 years old. Patients who completed less than 52 days of radiation therapy found to have a better prognosis than those receiving radiation for a longer period. Our multivariate analysis indicated that age, radiation period and N-factor were statistically significant in influencing prognosis. Hearing loss occured relatively high with 2096 of cumulative incidence in our study, probably because they received radiation therapy with the extended field including bilateral midle and inner ear. Extended-field radiotherapy for patients with nasopharyngeal carcinoma might contribute to improving their cure-rate, and precise radiation planning is warranted to avoid the late complications such as hearing loss.",
keywords = "Nasopharyngeal cancer, Prognostic factor, Radiotherapy",
author = "Naoyuki Shigematsu and Hisao Ito and Yosuke Oki and Tetsuya Kawada and Takayuki Suzuki and Atsuya Takeda and Minoru Uematsu and Atsushi Kubo and Masato Fujii and Hitoshi Kanzaki",
year = "1996",
month = "12",
language = "English",
volume = "56",
pages = "1050--1055",
journal = "Nippon Acta Radiologica",
issn = "0048-0428",
publisher = "Japan Radiological Society",
number = "14",

}

TY - JOUR

T1 - Prognostic Factors of Nasopharyngeal Carcinoma Treated by Radiotherapy

AU - Shigematsu, Naoyuki

AU - Ito, Hisao

AU - Oki, Yosuke

AU - Kawada, Tetsuya

AU - Suzuki, Takayuki

AU - Takeda, Atsuya

AU - Uematsu, Minoru

AU - Kubo, Atsushi

AU - Fujii, Masato

AU - Kanzaki, Hitoshi

PY - 1996/12

Y1 - 1996/12

N2 - This study was a retrospective analysis of 82 patients with histologically confirmed nasopharyngeal carcinoma, who were treated at Keio University Hospital from March 1983 to March 1993. We studied all cases (62% of them were stage IV) with regard to their prognostic factors and chronic side effects induced by radiation. All patients were received extended-field radiotherapy from the base of the skull to the supraclaviclar lymph node area. The five- and ten-year overall survival rates for the entire group were 59% and 49%, respectively. Three stage I patients were alive without recurrence or métastases for more than 5 years. The ten-year survival rate stage II-III for patients (23 patients) was 78%, and for stage IV (56 patients) 37%. The five-year survival rate of patients in T2-3 group without lymph node metastasis was 88%, while it was reduced to 55% for patients with metastasis. The prognosis of T4 patients was very poor: their five-year survival rate was 37% with lymph node metastasis, and 35%, without lymph node metastasis. Patients under 46 years old showed an increased survival rate compared with patients over 46 years old. Patients who completed less than 52 days of radiation therapy found to have a better prognosis than those receiving radiation for a longer period. Our multivariate analysis indicated that age, radiation period and N-factor were statistically significant in influencing prognosis. Hearing loss occured relatively high with 2096 of cumulative incidence in our study, probably because they received radiation therapy with the extended field including bilateral midle and inner ear. Extended-field radiotherapy for patients with nasopharyngeal carcinoma might contribute to improving their cure-rate, and precise radiation planning is warranted to avoid the late complications such as hearing loss.

AB - This study was a retrospective analysis of 82 patients with histologically confirmed nasopharyngeal carcinoma, who were treated at Keio University Hospital from March 1983 to March 1993. We studied all cases (62% of them were stage IV) with regard to their prognostic factors and chronic side effects induced by radiation. All patients were received extended-field radiotherapy from the base of the skull to the supraclaviclar lymph node area. The five- and ten-year overall survival rates for the entire group were 59% and 49%, respectively. Three stage I patients were alive without recurrence or métastases for more than 5 years. The ten-year survival rate stage II-III for patients (23 patients) was 78%, and for stage IV (56 patients) 37%. The five-year survival rate of patients in T2-3 group without lymph node metastasis was 88%, while it was reduced to 55% for patients with metastasis. The prognosis of T4 patients was very poor: their five-year survival rate was 37% with lymph node metastasis, and 35%, without lymph node metastasis. Patients under 46 years old showed an increased survival rate compared with patients over 46 years old. Patients who completed less than 52 days of radiation therapy found to have a better prognosis than those receiving radiation for a longer period. Our multivariate analysis indicated that age, radiation period and N-factor were statistically significant in influencing prognosis. Hearing loss occured relatively high with 2096 of cumulative incidence in our study, probably because they received radiation therapy with the extended field including bilateral midle and inner ear. Extended-field radiotherapy for patients with nasopharyngeal carcinoma might contribute to improving their cure-rate, and precise radiation planning is warranted to avoid the late complications such as hearing loss.

KW - Nasopharyngeal cancer

KW - Prognostic factor

KW - Radiotherapy

UR - http://www.scopus.com/inward/record.url?scp=0030338794&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030338794&partnerID=8YFLogxK

M3 - Article

C2 - 9014467

AN - SCOPUS:0030338794

VL - 56

SP - 1050

EP - 1055

JO - Nippon Acta Radiologica

JF - Nippon Acta Radiologica

SN - 0048-0428

IS - 14

ER -